Managedhealthcareexecutive
Published November 10, 2026
As psychedelic drugs near FDA decisions, people with HIV remain absent from trials ...
Read the full story at Managedhealthcareexecutive
Psychedelic therapies are nearing FDA decisions, but people with HIV, many covered by Medicaid, have been left out of nearly all trials,.
Surfaced by 2 Google Alerts
- Psychedelics
- MDMA